article thumbnail

Why is Oncology Drug Development Research Late to the Digital Biomarkers Game?

ActiGraph

There were more than 5000+ scientific abstracts presented during this event, yet only a handful involved the use of motion-tracking wearables to collect digital measures relating to activity, sleep, mobility, functional status, and/or quality of life.

article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

Palantir's software is able to make predictions about future events. Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Foundry can be used to identify patterns and trends in data, and to make predictions about future events.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

Digital Health Global

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

article thumbnail

Palantir and Healthcare: What could the future hold?

Lloyd Price

Palantir's software is able to make predictions about future events. Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Foundry can be used to identify patterns and trends in data, and to make predictions about future events. Have a comment?

article thumbnail

Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)

Digital Health Global

Johnson Centre for Cancer Research at Queen’s University Belfast to spearhead development of the next generation of glyco-immune therapeutics. Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

When we hear about an engagement in the typical sense, we associate it with and look forward to a momentous event: the wedding. But returning to Erin Moore’s point, how do we get researchers, clinicians, and industry engaged to listen to patients in clinical trial design, pharma/biotech drug development and health tech capability?

BioTech 110
article thumbnail

#091: Francesca Wuttke on Digital Transformation, Startups and Corporate Relationships

Digital Health Today

Francesca has over 20 years of drug development and healthcare expertise in both the US and Europe, and most recently, she led European investments as Managing Director for the MSD Global Health Innovation Fund and previously held roles at Novartis and Mount Sinai school of medicine, just to name a few. Digital Health Events.